Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD,...
-
Upload
jovan-esser -
Category
Documents
-
view
214 -
download
1
Transcript of Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD,...
![Page 1: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/1.jpg)
Institutional Review Board for Institutional Review Board for Human Research (IRB)Human Research (IRB)
Human Subject ProtectionsHuman Subject Protections
Susan Sonne, PharmD, BCPPSusan Sonne, PharmD, BCPP
Chair, MUSC IRB IIChair, MUSC IRB II
![Page 2: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/2.jpg)
Nuremberg CodeNuremberg Code
first major control on research in any nation
prescribed 1948 as part of trial of a Nazi Physician
willfully harmful research on unwilling human subjects
![Page 3: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/3.jpg)
Jewish Chronic Disease Hospital Jewish Chronic Disease Hospital StudyStudy
• July 1963
• Injection of live cancer cells into 22 patients
• No written consent
• Some verbally informed – “involved in experiment”
Never told being given live cancer cells
• Guilty of fraud, deceit, unprofessional conduct
![Page 4: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/4.jpg)
The Declaration of HelsinkiThe Declaration of Helsinki
Produced 1961, adapted 1964
Informed consent = ethical research
Basis for FDA policy
![Page 5: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/5.jpg)
Willowbrook State SchoolWillowbrook State School
Study began 1956
Institution for “mentally defective” children
Study designed to contribute to understanding etiology of infectious hepatitis and test effects of gamma globulin in preventing disease.
First subjects fed extracts of infected stool
Public attention 1971
![Page 6: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/6.jpg)
National Research Act of 1974National Research Act of 1974
Created National commission for the protection of Human Subjects of Biomedical and Behavioral research.
Charge was to:
Identify basic ethical principles that should underlie conduct of biomedical and behavioral research involving human subjects
![Page 7: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/7.jpg)
More specifically, considerMore specifically, consider
Boundaries between research and practice
Role of assessment of risk-benefit
Selection of subjects
Nature and definition of informed consent
Result was 1976 Belmont report
![Page 8: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/8.jpg)
Good Clinical Practice
Why have this training?
![Page 9: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/9.jpg)
The Tuskegee Syphilis StudyThe Tuskegee Syphilis Study
1932 to 19721932 to 1972 399 African American 399 African American
Males were denied Males were denied treatment for syphilistreatment for syphilis
Study conducted by Study conducted by U.S. Public Health U.S. Public Health ServiceService
![Page 10: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/10.jpg)
From President ClintonFrom President Clinton
"Although these regulations [Protection of Human Subjects, Code "Although these regulations [Protection of Human Subjects, Code of Federal Regulations, Title 45, Part 46} provide the framework for of Federal Regulations, Title 45, Part 46} provide the framework for protecting human subjects in research, we must exercise constant protecting human subjects in research, we must exercise constant care and ensure that these regulations are strictly enforced by care and ensure that these regulations are strictly enforced by departments and agencies. Therefore, I direct each department and departments and agencies. Therefore, I direct each department and agency of Government to review present practices to assure agency of Government to review present practices to assure compliance with the Federal Policy for the Protection of Human compliance with the Federal Policy for the Protection of Human Subjects and to cease immediately sponsoring or conducting any Subjects and to cease immediately sponsoring or conducting any experiments involving humans that do not fully comply with the experiments involving humans that do not fully comply with the Federal Policy." -Bill Clinton, 1994 Federal Policy." -Bill Clinton, 1994
““The people who ran the study at Tuskegee diminished the stature The people who ran the study at Tuskegee diminished the stature of man by abandoning the most basic ethical precepts. They forgot of man by abandoning the most basic ethical precepts. They forgot their pledge to heal and repair. They had the power to heal the their pledge to heal and repair. They had the power to heal the survivors and all the others and they did not. Today, all we can do survivors and all the others and they did not. Today, all we can do is apologize….” – Bill Clinton, 1997is apologize….” – Bill Clinton, 1997
![Page 11: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/11.jpg)
OHRP SuspensionsOHRP Suspensions
During the last 6-7 years, OHRP has During the last 6-7 years, OHRP has suspended all human research at the suspended all human research at the following institutions:following institutions:– University of Illinois, Chicago CampusUniversity of Illinois, Chicago Campus– University of ColoradoUniversity of Colorado– Duke UniversityDuke University– Johns HopkinsJohns Hopkins– University of PennsylvaniaUniversity of Pennsylvania– And othersAnd others
![Page 12: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/12.jpg)
General Rule for Human Subject General Rule for Human Subject ProtectionProtection
Any element of research?
Yes
Undergo review
![Page 13: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/13.jpg)
IRB PurposeIRB Purpose
To protect the rights and welfare of human To protect the rights and welfare of human research subjectsresearch subjects
Authority to approve, require modification Authority to approve, require modification and disapprove any research involving and disapprove any research involving human subjectshuman subjects
![Page 14: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/14.jpg)
Institutional Review BoardInstitutional Review Board• responsible to verify
1. Safety
2. Integrity
3. Human rights
4. Public reassurance
5. Scientific content
![Page 15: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/15.jpg)
The Belmont ReportThe Belmont Report
3 Basic Principles for Protection of Human Subjects:3 Basic Principles for Protection of Human Subjects:– RespectRespect
voluntary informed consentvoluntary informed consent privacyprivacy protections for vulnerable populations protections for vulnerable populations
– BeneficenceBeneficence– JusticeJustice
![Page 16: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/16.jpg)
BeneficenceBeneficence
Persons treated in an ethical manner
Protecting them from harm
Helping to secure their well being
![Page 17: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/17.jpg)
JusticeJustice
• Who ought to receive the benefits of research and bear the burden of research?
• Equals ought to be treated equally
• Fairness in distribution
• What is deserved
![Page 18: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/18.jpg)
Criteria for ApprovalCriteria for Approval
Risks are minimizedRisks are minimized Reasonable risk:benefit ratio Reasonable risk:benefit ratio Equitable selection of subjectsEquitable selection of subjects Informed consent obtained appropriatelyInformed consent obtained appropriately Informed consent adequately documentedInformed consent adequately documented Monitor data to insure safetyMonitor data to insure safety Protect confidentialityProtect confidentiality No coercionNo coercion
![Page 19: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/19.jpg)
Informed Consent• Essential to ethical conduct of clinical
investigation
• Potential subject chooses whether or not they will participate
• Obtained after full information is given and understood
• Explanation of study objective, potential benefits, risks, inconveniences, subject’s rights and responsibilities
![Page 20: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/20.jpg)
Informed Consent–Introduction –Purpose of the Study–Procedures–Potential Risks and Discomforts–Anticipated Benefits to Subjects–Anticipated Benefits to Society–Alternative to Participation–Emergency Care and Compensation for Injury–Payment for Participation–Financial Obligation–Privacy and Confidentiality–Participation and Withdrawal–Rights of Research Subjects–Signatures
![Page 21: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/21.jpg)
•Protecting Participants•Implementing Study•Reporting Accurately
The Mountain of Responsibility
![Page 22: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/22.jpg)
Investigator Obligations• Conducts a clinical investigation
• Responsible for
All procedures conducted
All data collected
• May delegate work in conducting study but they retain responsibility
![Page 23: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/23.jpg)
Investigators – and by delegation all study staff responsibilities
• To protect the rights of participants• To obtain informed consent from each
participant• To keep specific records and issue
specific orders• To assure that the IRB is provided
information for initial and continuing review of the study
![Page 24: Institutional Review Board for Human Research (IRB) Human Subject Protections Susan Sonne, PharmD, BCPP Chair, MUSC IRB II.](https://reader035.fdocuments.in/reader035/viewer/2022062712/56649cab5503460f9496b933/html5/thumbnails/24.jpg)
Useful Regulatory/Policy MaterialUseful Regulatory/Policy Material
MUSC IRBMUSC IRB http://research.musc.edu/ori/irb/homehttp://research.musc.edu/ori/irb/home Office for Human Research ProtectionsOffice for Human Research Protections http://www.hhs.gov/ohrp/http://www.hhs.gov/ohrp/ Food & Drug AdministrationFood & Drug Administration http://www.fda.gov/oc/ohrt/irbs/default.htmhttp://www.fda.gov/oc/ohrt/irbs/default.htm